Cassava Sciences Files 8-K for Financials

TL;DR

Cassava Sciences filed an 8-K for financial statements and exhibits on 9/17.

AI Summary

Cassava Sciences, Inc. filed an 8-K on September 17, 2024, reporting an event that occurred on September 13, 2024. The filing is primarily for financial statements and exhibits, with no specific details on other events provided in the excerpt.

Why It Matters

This filing indicates Cassava Sciences is providing updated financial information or exhibits to the SEC, which could be relevant for investors assessing the company's financial health.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for financial statements and exhibits, not indicating any immediate material adverse events.

Key Numbers

• 001-41905 — SEC File Number (Identifies the company's filing history with the SEC.)
• 91-1911336 — I.R.S. Employer Identification Number (Company's tax identification number.)

Key Players & Entities

• Cassava Sciences, Inc. (company) — Registrant
• September 13, 2024 (date) — Earliest event reported
• September 17, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• Austin, Texas (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ge on which registered Common Stock , $0.001 par value SAVA Nasdaq Capital Market
• $100 — days' notice. Mr. Barbier will be paid $100 per hour for such consulting services.

Filing Documents

• sava20240917_8k.htm (8-K) — 30KB
• ex_724740.htm (EX-10.1) — 51KB
• 0001437749-24-029380.txt ( ) — 225KB
• sava-20240913.xsd (EX-101.SCH) — 3KB
• sava-20240913_def.xml (EX-101.DEF) — 12KB
• sava-20240913_lab.xml (EX-101.LAB) — 15KB
• sava-20240913_pre.xml (EX-101.PRE) — 12KB
• sava20240917_8k_htm.xml (XML) — 3KB

01. Other Events

Item 8.01. Other Events. On September 13, 2024, Cassava Sciences, Inc. (the "Company" or "Cassava") entered into a non-exclusive Consulting Agreement (the "Consulting Agreement") with Remi Barbier, the Company's former Chief Executive Officer. Pursuant to the Consulting Agreement, for a period of one year, Mr. Barbier will furnish consulting services as, and to the extent, reasonably requested by Cassava for purposes of providing information and support for scientific research and/or obtaining governmental approval for the Company's products. Cassava may, in its sole discretion, extend the term of the Consulting Agreement for up to an additional year. Either party may terminate the Consulting Agreement at any time with thirty days' notice. Mr. Barbier will be paid $100 per hour for such consulting services. Pursuant to the Consulting Agreement, Mr. Barbier also provides confidentiality and other customary covenants, terms and conditions during the Consulting Agreement's term. The Consulting Agreement does not alter Mr. Barbier's severance benefits, which were described in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on July 17, 2024. The foregoing description of the Consulting Agreement is only a summary and is qualified in its entirety by reference to the full text of the Consulting Agreement, which is attached as Exhibit 10.1 hereto and incorporated into this Item 8.01 by reference. 9.01: Financial Statements and Exhibits Exhibit No. Description 10.1 Barbier Consulting Agreement dated September 13, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CASSAVA SCIENCES, INC. a Delaware corporation Date: September 17, 2024 By: /s/ Eric J. Schoen Eric J. Schoen

View Full Filing

View this 8-K filing on SEC EDGAR